Speakers

 

 

Luiza Abdo, Doctor, Brazilian National Cancer Institute

Luiza Abdo | Doctor | Brazilian National Cancer Institute » speaking at Advanced Therapies USA

James Adams, Chief Technical Officer, Tr1x, Inc

James Adams | Chief Technical Officer | Tr1x, Inc » speaking at Advanced Therapies USA

Blake Aftab, Chief Scientific Officer, Adicet Bio

Faizzan Ahmad, Chief Executive Officer, Cure8bio

Faizzan Ahmad | Chief Executive Officer | Cure8bio » speaking at Advanced Therapies USA

Pavel Aprelev, Director of Corporate Development, Verismo Therapeutics

Pavel Aprelev | Director of Corporate Development | Verismo Therapeutics » speaking at Advanced Therapies USA

Sean Armour, VP, Head of Discovery, Roche Innovation Center

Sean Armour | VP, Head of Discovery | Roche Innovation Center » speaking at Advanced Therapies USA

Jared Auclair, Director of Bioinnovation, Northeastern University

Jared Auclair | Director of Bioinnovation | Northeastern University » speaking at Advanced Therapies USA

Daniel Baker, PhD Candidate, June Lab, University of Pennsylvania School Of Medicine

Daniel Baker | PhD Candidate, June Lab | University of Pennsylvania School Of Medicine » speaking at Advanced Therapies USA

Christopher Ballas, Chief Technology Officer, Castle Creek Biosciences

Christopher Ballas | Chief Technology Officer | Castle Creek Biosciences » speaking at Advanced Therapies USA

Priya Baraniak, Chief Commercial and Development Officer, Pluristyx, Inc.

Shirley Bartido, Director, Global Regulatory Affairs Oncology Cell Therapy, Takeda

Cecile Bauche, Chief Scientific Officer, Alaya.bio

Cecile Bauche | Chief Scientific Officer | Alaya.bio » speaking at Advanced Therapies USA

Alexandra Beumer Sassi, Executive Director, CMC Regulatory Affairs, AstraZeneca

Seema Bhatlekar, Principal Scientist, Gene Therapy Process Development, Johnson & Johnson Innovative Medicine

Seema Bhatlekar | Principal Scientist, Gene Therapy Process Development | Johnson & Johnson Innovative Medicine » speaking at Advanced Therapies USA

Gwendolyn Binder, President of Science and Technology, Cabaletta Bio

Gwendolyn Binder | President of Science and Technology | Cabaletta Bio » speaking at Advanced Therapies USA

Petter Bjorquist, CEO, VERIGRAFT AB

Petter Bjorquist | CEO | VERIGRAFT AB » speaking at Advanced Therapies USA

Jaap Jan Boelens, Chief, Transplantation and Cellular Therapies, Memorial Sloan-Kettering Cancer Center

Catherine Bollard, Senior Vice President & Chief Research Officer, Children's National Hospital

Catherine Bollard | Senior Vice President & Chief Research Officer | Children's National Hospital » speaking at Advanced Therapies USA

Martin Bonamino, Head of Cell and Gene Therapy Program, National Cancer Institute of Brazil

Anne Brooks, Senior Vice President, US Commercial, Iovance Biotherapeutics

Frederic Bushman, Professor and Chair, Department of Microbiology, Co-Director PennCHOP Microbiome Program, Perelman School of Medicine at the University of Pennsylvania

Omer Butt, Vice President, Regulatory Affairs, CytoImmune Therapeutics

Omer Butt | Vice President, Regulatory Affairs | CytoImmune Therapeutics » speaking at Advanced Therapies USA

Ying Cai, Executive Director, Manufacturing Science and Technology, Ultragenyx Pharmaceutical Inc.

Marcus Calkins, Director of Scientific Communication, Genomefrontier Therapeutics Inc

Marcus Calkins | Director of Scientific Communication | Genomefrontier Therapeutics Inc » speaking at Advanced Therapies USA

Yu (Clay) Cao, Vice President, Global Head of Drug Discovery, GenEditBio Limited

Pedro Cejas, Head of New Therapeutic Modalities, Spark Therapeutics

Pedro Cejas | Head of New Therapeutic Modalities | Spark Therapeutics » speaking at Advanced Therapies USA

Guobao Chen, Principal Research Scientist, AbbVie

Therese Choquette, Head of Analytical and Translational Sciences, Tigen Pharma

Therese Choquette | Head of Analytical and Translational Sciences | Tigen Pharma » speaking at Advanced Therapies USA

Daniel Cohen, Head of Vector Optimization, Roche Innovation Center

Daniel Cohen | Head of Vector Optimization | Roche Innovation Center » speaking at Advanced Therapies USA

Caralynn Collens, CEO, Dimension Bio

Caralynn Collens | CEO | Dimension Bio » speaking at Advanced Therapies USA

Angela Columbano, Head Business Development and Partnership, Genethon

Angela Columbano | Head Business Development and Partnership | Genethon » speaking at Advanced Therapies USA

Amanda Conerty, Executive Director, Manufacturing, Advocacy and Engagement, Artiva Biotherapeutics

Terry Cothran, Senior Pharmacy Director, Oklahoma Health Care Authority

Terry Cothran | Senior Pharmacy Director | Oklahoma Health Care Authority » speaking at Advanced Therapies USA

Arun Das, Chief Business Officer, Cabaletta Bio

Houman Dehghani, Vice President, Technical Development, Cabaletta Bio

Houman Dehghani | Vice President, Technical Development | Cabaletta Bio » speaking at Advanced Therapies USA

Arnaud Deladeriere, President and Principal Consultant, Cell&Gene Consulting

Arnaud Deladeriere | President and Principal Consultant | Cell&Gene Consulting » speaking at Advanced Therapies USA

Virginie Delwart, Director Patient Advocacy - Hematology, Oncology, Gene Therapy (CRISPR)/Rare Disease, Ophthalmology, Regeneron

Virginie Delwart | Director Patient Advocacy - Hematology, Oncology, Gene Therapy (CRISPR)/Rare Disease, Ophthalmology | Regeneron » speaking at Advanced Therapies USA

Wenjun Di, Senior Scientist, Ultragenyx Pharmaceutical Inc.

Wenjun Di | Senior Scientist | Ultragenyx Pharmaceutical Inc. » speaking at Advanced Therapies USA

Daniel Dornbusch, CEO, Excision Biotherapeutics

Daniel Dornbusch | CEO | Excision Biotherapeutics » speaking at Advanced Therapies USA

Tracy Dowling, Chief Business Officer & General Counsel, AskBio

Tracy Dowling | Chief Business Officer & General Counsel | AskBio » speaking at Advanced Therapies USA

Mark Duckworth, Sr. Director Cellular and Gene Therapy Operations, Children's Hospital Of Philadelphia

Mark Duckworth | Sr. Director Cellular and Gene Therapy Operations | Children's Hospital Of Philadelphia » speaking at Advanced Therapies USA

Mark Dudley, Consultant, Independent Advisors

Mark Dudley | Consultant | Independent Advisors » speaking at Advanced Therapies USA

Kate Excoffon, Founder and CEO, Gene Tx Optimized, LLC

Madelyn Fell, Director of Operations, Cell Therapy and Transplant, University of Pennsylvania Health System

Madelyn Fell | Director of Operations, Cell Therapy and Transplant | University of Pennsylvania Health System » speaking at Advanced Therapies USA

Miguel Forte, CEO, Kiji Tx

Miguel Forte | CEO | Kiji Tx » speaking at Advanced Therapies USA

Peter Francis, Chief Scientific Officer and Chief Medical Officer, Ray Therapeutics

Nelson Freeburg, Post-doc Researcher, University of Pennsylvania

Benjamin Fryer, CEO, Pluristyx Inc

Benjamin Fryer | CEO | Pluristyx Inc » speaking at Advanced Therapies USA

Patrick Gailliot, Sr. Director, Patient Operations, Abeona Therapeutics

Hugh Gannon, Associate Director, KSQ Therapeutics, Inc.

Hugh Gannon | Associate Director | KSQ Therapeutics, Inc. » speaking at Advanced Therapies USA

Anthony Garcia, Chief Quality Officer, AstroBio Solutions

Anthony Garcia | Chief Quality Officer | AstroBio Solutions » speaking at Advanced Therapies USA

Maurits Geerlings, President & CEO, NanoCell Therapeutics

David Geoghegan, SVP, Head of Quality and Validation, Spark Therapeutics

David Geoghegan | SVP, Head of Quality and Validation | Spark Therapeutics » speaking at Advanced Therapies USA

Mahnoor Gondal, PhD Candidate, University of Michigan

Mahnoor Gondal | PhD Candidate | University of Michigan » speaking at Advanced Therapies USA

Thorsten Gorba, VP, Process & Analytical Development, Aspen Neuroscience, Inc.

Thorsten Gorba | VP, Process & Analytical Development | Aspen Neuroscience, Inc. » speaking at Advanced Therapies USA

Dave Greenwald, Vice President Of Business Development, Deerfield Management

Dave Greenwald | Vice President Of Business Development | Deerfield Management » speaking at Advanced Therapies USA

Xuecui Guo, Director of Gene Regulation, Meiragtx

Xuecui Guo | Director of Gene Regulation | Meiragtx » speaking at Advanced Therapies USA

Eric Hacherl, Chief Operating Officer, Kyttaro Therapeutics

Eric Hacherl | Chief Operating Officer | Kyttaro Therapeutics » speaking at Advanced Therapies USA

Erin Harris, Chief Editor, Cell & Gene

Christina Hartman, Senior Director, Government Affairs, Orchard therapeutics

Christina Hartman | Senior Director, Government Affairs | Orchard therapeutics » speaking at Advanced Therapies USA

Stephanie Heathman, Business Development Lead, Opie Jones Foundation

Stephanie Heathman | Business Development Lead | Opie Jones Foundation » speaking at Advanced Therapies USA

Friederike Herbst-Nowrouzi, Director of the Human Genome Editing Laboratory (HGEL), Perelman School of Medicine University of Pennsylvania

Friederike Herbst-Nowrouzi | Director of the Human Genome Editing Laboratory (HGEL) | Perelman School of Medicine University of Pennsylvania » speaking at Advanced Therapies USA

Steven Highfill, Director of Product Development, Center for Cellular Engineering, Clinical Center, National Institutes of Health

Steven Highfill | Director of Product Development, Center for Cellular Engineering, Clinical Center | National Institutes of Health » speaking at Advanced Therapies USA

Jenny Holt, Chief Development Officer, Ray Therapeutics

Amy House, VP Corporate Development and Communications, Beacon Therapeutics

Amy House | VP Corporate Development and Communications | Beacon Therapeutics » speaking at Advanced Therapies USA

Xiao Huang, Assistant Professor, Precision Immune Engineering Laboratory, Drexel University

Xiao Huang | Assistant Professor, Precision Immune Engineering Laboratory | Drexel University » speaking at Advanced Therapies USA

Ruud Hulspas, Technical Director Process Development, Dana-Farber Cancer Institute

Kaiyuan Jiang, Associate Director, API Cell Therapy, Johnson & Johnson Pharmaceutical R&D

Kaiyuan Jiang | Associate Director, API Cell Therapy | Johnson & Johnson Pharmaceutical R&D » speaking at Advanced Therapies USA

Quan Jin, Associate Director, Capsid Engineering, Spark Therapeutics

Quan Jin | Associate Director, Capsid Engineering | Spark Therapeutics » speaking at Advanced Therapies USA

Rita Johnson-Greene, Chief Operating Officer, Alliance for Regenerative Medicine

Rita Johnson-Greene | Chief Operating Officer | Alliance for Regenerative Medicine » speaking at Advanced Therapies USA

Jennifer Johnston, Cofounder and CEO, NysnoBio

Micheala Jones, Lead, Global Medical Affairs, Hemophilia Gene Editing (CRISPR/Cas9) and Thrombosis, Regeneron

Micheala Jones | Lead, Global Medical Affairs, Hemophilia Gene Editing (CRISPR/Cas9) and Thrombosis | Regeneron » speaking at Advanced Therapies USA

Margareth Jorvid, Board Member, Elicera Therapeutics

Angela Justice, Executive Coach & Advisor, Justice Group Advisors

Angela Justice | Executive Coach & Advisor | Justice Group Advisors » speaking at Advanced Therapies USA

Stephan Kadauke, Associate Professor of Clinical Pathology and Lab Medicine, The Children's Hospital of Philadelphia

Stephan Kadauke | Associate Professor of Clinical Pathology and Lab Medicine | The Children's Hospital of Philadelphia » speaking at Advanced Therapies USA

Lisa Kahlman, Executive Director, Public Policy & Public affairs, Ultragenyx Pharmaceutical Inc.

Lisa Kahlman | Executive Director, Public Policy & Public affairs | Ultragenyx Pharmaceutical Inc. » speaking at Advanced Therapies USA

Hemachandran Kannan, Director, Woxsen University

Hemachandran Kannan | Director | Woxsen University » speaking at Advanced Therapies USA

William Kearns, Chief Executive Officer and CSO, Genzeva

William Kearns | Chief Executive Officer and CSO | Genzeva » speaking at Advanced Therapies USA

Saad Kenderian, Co Leader, Cancer Immunology and Immunotherapy, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic

Saad Kenderian | Co Leader, Cancer Immunology and Immunotherapy, Mayo Clinic Comprehensive Cancer Center | Mayo Clinic » speaking at Advanced Therapies USA

Daniel KIlbank, CSO, Mygogenesis LLC

Daniel KIlbank | CSO | Mygogenesis LLC » speaking at Advanced Therapies USA

Matt Killeen, President, TikkunLev Therapeutics

Matt Killeen | President | TikkunLev Therapeutics » speaking at Advanced Therapies USA

Dan Kirby, Chief Commercial Officer, Iovance Biotherapeutics

Eric Kmiec, Founder & CEO, CorriXR Therapeutics

Eric Kmiec | Founder & CEO | CorriXR Therapeutics » speaking at Advanced Therapies USA

Roland Kolbeck, Chief Scientific Officer, Spirovant Sciences

Roland Kolbeck | Chief Scientific Officer | Spirovant Sciences » speaking at Advanced Therapies USA

Brett Kopelan. MA, Executive Director, DebRa of America

Brett Kopelan. MA | Executive Director | DebRa of America » speaking at Advanced Therapies USA

Nidhi Kotecha, Program Director, Regulatory Affairs, Gates Institute

Nidhi Kotecha | Program Director, Regulatory Affairs | Gates Institute » speaking at Advanced Therapies USA

Kat Kozyrytska, Founder, Cell Therapy Manufacturability Program

Kat Kozyrytska | Founder | Cell Therapy Manufacturability Program » speaking at Advanced Therapies USA

Ashley Krull, Associate Director, Cell Therapy Manufacturing and Engineering, The Ohio State University Wexner Medical Center

Joanne Kurtzberg, Director, Marcus Center For Cellular Cures,, Duke University Medical Center

Joanne Kurtzberg | Director, Marcus Center For Cellular Cures, | Duke University Medical Center » speaking at Advanced Therapies USA

Simon Lacey, Vice President - Immunology, Asklepios BioPharmaceutical, Inc. (AskBio)

Simon Lacey | Vice President - Immunology | Asklepios BioPharmaceutical, Inc. (AskBio) » speaking at Advanced Therapies USA

Graeme Ladds, CEO, PharSafer

Michael Lehmicke, Sr. Vice President, Science & Industry Affairs, Alliance for Regenerative Medicine

Michael Lehmicke | Sr. Vice President, Science & Industry Affairs | Alliance for Regenerative Medicine » speaking at Advanced Therapies USA

Bruce Levine, Barbara and Edward Netter Professor in Cancer Gene Therapy, Perelman School of Medicine University of Pennsylvania

Yan Li, Senior Director, Process Development, Cabaletta Bio

Yan Li | Senior Director, Process Development | Cabaletta Bio » speaking at Advanced Therapies USA

Kirstin Liechty, Sr. Director, Clinical Operations, A2 Biotherapeutics

Kirstin Liechty | Sr. Director, Clinical Operations | A2 Biotherapeutics » speaking at Advanced Therapies USA

Hernando Lopez-Bertoni, Associate Professor, Johns Hopkins Medicine

Hernando Lopez-Bertoni | Associate Professor | Johns Hopkins Medicine » speaking at Advanced Therapies USA

Tom Lowery, President & CEO, Satellite Bio

Tom Lowery | President & CEO | Satellite Bio » speaking at Advanced Therapies USA

Raymond Luke, Senior Director, MSAT, Verismo Therapeutics

Raymond Luke | Senior Director, MSAT | Verismo Therapeutics » speaking at Advanced Therapies USA

Deepu Madduri, Senior Director, Compound Development Team Lead, CARVYKTI, Johnson & Johnson

Deepu Madduri | Senior Director, Compound Development Team Lead, CARVYKTI | Johnson & Johnson » speaking at Advanced Therapies USA

Martin Maiers, VP, Research, NMDP

Martin Maiers | VP, Research | NMDP » speaking at Advanced Therapies USA

Stephanie Maistrellis, CEO, Lead Life Sciences

Stephanie Maistrellis | CEO | Lead Life Sciences » speaking at Advanced Therapies USA

Kimberly Malecka, Senior Scientist, Spark Therapeutics

Kimberly Malecka | Senior Scientist | Spark Therapeutics » speaking at Advanced Therapies USA

Aziza Manceur, Research Officer, National Research Council Canada

Aziza Manceur | Research Officer | National Research Council Canada » speaking at Advanced Therapies USA

Craig Martin, Founder, CEO, Orphan Therapeutics Accelerator

Craig Martin | Founder, CEO | Orphan Therapeutics Accelerator » speaking at Advanced Therapies USA

Lauren Martz, Executive Director, Biopharma Intelligence, BioCentury Inc

Lauren Martz | Executive Director, Biopharma Intelligence | BioCentury Inc » speaking at Advanced Therapies USA

Melissa Maxwell, Director of Research and Program Management, Phio Pharmaceuticals Corp.

Domhnall McGowan, Regional Manager - GMP Sites and Training, Canadian Advanced Therapies Training Institute

Domhnall McGowan | Regional Manager - GMP Sites and Training | Canadian Advanced Therapies Training Institute » speaking at Advanced Therapies USA

Michael McMahon, Professor, John Hopkins School Of Medicine

Michael McMahon | Professor | John Hopkins School Of Medicine » speaking at Advanced Therapies USA

Michael Mehler, Director, Cell Therapy Patient Operations, AstraZeneca

Michael Mehler | Director, Cell Therapy Patient Operations | AstraZeneca » speaking at Advanced Therapies USA

Fiona Miller, Managing Partner, quadraScope Ventures

Fiona Miller | Managing Partner | quadraScope Ventures » speaking at Advanced Therapies USA

Nadia Milne, Associate Director, Global Logistics Advanced Therapies | Clinical Supply Chain, Johnson & Johnson

Dara Missan, Staff Scientist, Process Development, Mayo Clinic

Dara Missan | Staff Scientist, Process Development | Mayo Clinic » speaking at Advanced Therapies USA

Samarendra Mohanty, President and Chief Scientific Officer, Nanoscope Therapeutics

Samarendra Mohanty | President and Chief Scientific Officer | Nanoscope Therapeutics » speaking at Advanced Therapies USA

David Morrow, Senior Scientific Programme Manager-ATMP/Vaccines, EATRIS

David Morrow | Senior Scientific Programme Manager-ATMP/Vaccines | EATRIS » speaking at Advanced Therapies USA

John Moscariello, Chief Technical Officer, Neuvogen Therapeutics

John Moscariello | Chief Technical Officer | Neuvogen Therapeutics » speaking at Advanced Therapies USA

Christopher Murriel, Vice President, Pre-Clinical Pharmacology, ArsenalBio

Christopher Murriel | Vice President, Pre-Clinical Pharmacology | ArsenalBio » speaking at Advanced Therapies USA

Nancy Nair, Executive Director, Global Regulatory Affairs, Oncology, Johnson & Johnson Innovative Medicine

Nancy Nair | Executive Director, Global Regulatory Affairs, Oncology | Johnson & Johnson Innovative Medicine » speaking at Advanced Therapies USA

Prachi Narayan, Global Product Quality and Stability Operations and Clinical Science, Independent Expert

Prachi Narayan | Global Product Quality and Stability Operations and Clinical Science | Independent Expert » speaking at Advanced Therapies USA

Alexander Natz, Secretary General, EUCOPE - European Confederation of Pharmaceutical Entrepreneurs

Kimberly Neff, Principal, Big Magic

Kimberly Neff | Principal | Big Magic » speaking at Advanced Therapies USA

Tony Newberne, Patient Advocate, Patient Advocate

Tony Newberne | Patient Advocate | Patient Advocate » speaking at Advanced Therapies USA

Cokey Nguyen, President and CEO, Atara Biotherapeutics

Cokey Nguyen | President and CEO | Atara Biotherapeutics » speaking at Advanced Therapies USA

Susan Nichols, Chief Executive Officer, Propel Biosciences

Susan Nichols | Chief Executive Officer | Propel Biosciences » speaking at Advanced Therapies USA

Sean O'Brien, Senior Scientist, AstraZeneca

Sean O'Brien | Senior Scientist | AstraZeneca » speaking at Advanced Therapies USA

Raphael Ognar, President & CEO, NKILT Therapeutics Inc.

Daniel Oliver, Chief Executive Officer And Founder, Rejuvenate Bio

Daniel Oliver | Chief Executive Officer And Founder | Rejuvenate Bio » speaking at Advanced Therapies USA

Nneka Onwudiwe, Former PRO/PE Regulatory Review Officer, Food and Drug Administration (FDA)

Nneka Onwudiwe | Former PRO/PE Regulatory Review Officer | Food and Drug Administration (FDA) » speaking at Advanced Therapies USA

Amy Pagliarulo, Senior Director Director of ATC Cell Therapy Operations, Iovance Biotherapeutics

Amy Pagliarulo | Senior Director Director of ATC Cell Therapy Operations | Iovance Biotherapeutics » speaking at Advanced Therapies USA

Parimal Pande, Associate Scientific Director, Johnson & Johnson

Parimal Pande | Associate Scientific Director | Johnson & Johnson » speaking at Advanced Therapies USA

Melissa Penn, Director Patient Engagement Research & Development, Bayer

Melissa Penn | Director Patient Engagement Research & Development | Bayer » speaking at Advanced Therapies USA

David Peritt, Chief Scientific Officer, Lupagen

David Peritt | Chief Scientific Officer | Lupagen » speaking at Advanced Therapies USA

Vicki Plaks, Senior Scientific Director and Head of Cell Therapy, Oncology Translational Research, Johnson & Johnson

Vicki Plaks | Senior Scientific Director and Head of Cell Therapy, Oncology Translational Research | Johnson & Johnson » speaking at Advanced Therapies USA

Nolan Polson, VP Quality Assurance and Product Quality, Iovance Biotherapeutics

Nolan Polson | VP Quality Assurance and Product Quality | Iovance Biotherapeutics » speaking at Advanced Therapies USA

David Porter, Director, Cell Therapy and Transplant, University of Pennsylvania

David Porter | Director, Cell Therapy and Transplant | University of Pennsylvania » speaking at Advanced Therapies USA

Brian Price, Chief Technology Officer, Armatus Bio, Inc

Brian Price | Chief Technology Officer | Armatus Bio, Inc » speaking at Advanced Therapies USA

Raj Puri, Chief Regulatory Officer, Iovance Biotherapeutics

Raj Puri | Chief Regulatory Officer | Iovance Biotherapeutics » speaking at Advanced Therapies USA

Huma Qamar, Chief Medical Officer, Ocugen

Huma Qamar | Chief Medical Officer | Ocugen » speaking at Advanced Therapies USA

Wenchun Qu, Associate Director of Centre for Regenerative Bio therapeutics in Florida, Mayo Clinic

Wenchun Qu | Associate Director of Centre for Regenerative Bio therapeutics in Florida | Mayo Clinic » speaking at Advanced Therapies USA

Shahrooz Rabizadeh, CEO & Co-Founder, Sagittarius Bio, Inc

Shahrooz Rabizadeh | CEO & Co-Founder | Sagittarius Bio, Inc » speaking at Advanced Therapies USA

Monica Raimo, Director of Product and Process Development, Glycostem Therapeutics

Monica Raimo | Director of Product and Process Development | Glycostem Therapeutics » speaking at Advanced Therapies USA

Lior Raviv, CTO, Pluri

Lior Raviv | CTO | Pluri » speaking at Advanced Therapies USA

Michael Riotto, Grassroots Advocacy Leader, International Myeloma Foundation

Blaine Robinson, Vice President, Therapy Acceleration Program, The Leukemia & Lymphoma Society

Kate Rochlin, Chief Operating Officer, IN8bio

Kate Rochlin | Chief Operating Officer | IN8bio » speaking at Advanced Therapies USA

Pedro Rodriguez, Associate Director, Clinical Supply Operations, Johnson & Johnson

Pedro Rodriguez | Associate Director, Clinical Supply Operations | Johnson & Johnson » speaking at Advanced Therapies USA

Qian Ruan, SVP of Technical Operations, Arcturus Therapeutics

Holger Russ, Associate Professor, University of Florida

Holger Russ | Associate Professor | University of Florida » speaking at Advanced Therapies USA

Arthur Sagoskin, Chief Executive Officer & Co-Founder, Mygogenesis

Arthur Sagoskin | Chief Executive Officer & Co-Founder | Mygogenesis » speaking at Advanced Therapies USA

Tay Salimullah, Venture Partner, 4BIO Capital

Tay Salimullah | Venture Partner | 4BIO Capital » speaking at Advanced Therapies USA

Jordan Schecter, Vice President | Multiple Myeloma DAS Leader, Johnson and Johnson

Jordan Schecter | Vice President   | Multiple Myeloma DAS Leader | Johnson and Johnson » speaking at Advanced Therapies USA

Eric Schuur, Chief Executive Officer, Hepatx Corporation

Eric Schuur | Chief Executive Officer | Hepatx Corporation » speaking at Advanced Therapies USA

Vishal Shah, Dean, Community College of Philadelphia

Vishal Shah | Dean | Community College of Philadelphia » speaking at Advanced Therapies USA

Nirav Shah, Associate Professor of Medicine, Director, BMT & Cellular Therapy Program, Medical College of Wisconsin

Nirav Shah | Associate Professor of Medicine, Director, BMT & Cellular Therapy Program | Medical College of Wisconsin » speaking at Advanced Therapies USA

Chris Shanks, Content Director, Terrapinn Holdings Ltd

Chris Shanks | Content Director | Terrapinn Holdings Ltd » speaking at Advanced Therapies USA

Daniel Shelly, Chief Business Development Officer, PolTREG AG

Daniel Shelly | Chief Business Development Officer | PolTREG AG » speaking at Advanced Therapies USA

Don Siegel, Director, Division of Transfusion Medicine & Therapeutic Pathology, Perelman School of Medicine University of Pennsylvania

Don Siegel | Director, Division of Transfusion Medicine & Therapeutic Pathology | Perelman School of Medicine University of Pennsylvania » speaking at Advanced Therapies USA

Dana Silverbush, Assistant Professor of Cancer Biology, University of Pennsylvania

Dana Silverbush | Assistant Professor of Cancer Biology | University of Pennsylvania » speaking at Advanced Therapies USA

Lara Silverman, Principal Consultant, Coeptis and LIS BioConsulting

Lara Silverman | Principal Consultant | Coeptis and LIS BioConsulting » speaking at Advanced Therapies USA

Justin Skoble, Vice President of Technical Operations, Caribou Biosciences

Devyn Smith, CEO, Arbor Biotechnologies

Devyn Smith | CEO | Arbor Biotechnologies » speaking at Advanced Therapies USA

Adam Snook, Associate Professor, Thomas Jefferson Unversity

Adam Snook | Associate Professor | Thomas Jefferson Unversity » speaking at Advanced Therapies USA

Mike Spencer, Vice President of Oncology Market Access, Johnson & Johnson

Mike Spencer | Vice President of Oncology Market Access | Johnson & Johnson » speaking at Advanced Therapies USA

Kara Spiller, URBN Professor of Biomedical Innovation, Drexel University

Antoine Sreih, Vice President, Medical Director, Cullinan Therapeutics, Inc.

Antoine Sreih | Vice President, Medical Director | Cullinan Therapeutics, Inc. » speaking at Advanced Therapies USA

Joseph Stavas, Senior Vice President of Clinical Development, ProKidney

Joseph Stavas | Senior Vice President of Clinical Development | ProKidney » speaking at Advanced Therapies USA

Matthias Stöcker, Regulatory Capability Lead, Boehringer Ingelheim International GmbH

Matthias Stöcker | Regulatory Capability Lead | Boehringer Ingelheim International GmbH » speaking at Advanced Therapies USA

Michael Storey, Former Medication Use Strategist, The Ohio State University and Nationwide Children’s Hospital

Michael Storey | Former Medication Use Strategist | The Ohio State University and Nationwide Children’s Hospital » speaking at Advanced Therapies USA

Ales Strancar, Managing Director, Sartorius BIA Separations

Victor Stukat Gren, Head of Strategy, AskBio

Victor Stukat Gren | Head of Strategy | AskBio » speaking at Advanced Therapies USA

Chris Tamburrini, Principal & Founder, RonanVance Search

Chris Tamburrini | Principal & Founder | RonanVance Search » speaking at Advanced Therapies USA

Kris Thiruvillakkat, Sr Director Global Market Access, CSL Behring

Kris Thiruvillakkat | Sr Director Global Market Access | CSL Behring » speaking at Advanced Therapies USA

Sarah Thomas, SVP, Quality, REGENXBIO

Prateek Tripathi, Senior Expert, Novartis Gene Therapies

Prateek Tripathi | Senior Expert | Novartis Gene Therapies » speaking at Advanced Therapies USA

Raisa Uchurova, Scientist, Century Therapeutics

Raisa Uchurova | Scientist | Century Therapeutics » speaking at Advanced Therapies USA

Arun Upadhyay, Chief Scientific Officer, Ocugen

Arun Upadhyay | Chief Scientific Officer | Ocugen » speaking at Advanced Therapies USA

Renaud Vaillant, CEO & co-Founder, Alaya.bio

Renaud Vaillant | CEO & co-Founder | Alaya.bio » speaking at Advanced Therapies USA

Jose Eduardo Vidal, Chief Executive Officer, CytoImmune Therapeutics

Jose Eduardo Vidal | Chief Executive Officer | CytoImmune Therapeutics » speaking at Advanced Therapies USA

Pierre Axel Vinot, Director, CMC Portfolio Management, SparingVision

Nelly Viseux, VP, Cell Therapies Development, Manufacturing, Supply & Quality, Regeneron

Nelly Viseux | VP, Cell Therapies Development, Manufacturing,  Supply & Quality | Regeneron » speaking at Advanced Therapies USA

Francesca Vitelli, Consultant, FPV Advisors

Francesca Vitelli | Consultant | FPV Advisors » speaking at Advanced Therapies USA

Jim Wang, VP, Global Regulatory Strategy, Genetic Medicines, Regeneron

Jim Wang | VP, Global Regulatory Strategy, Genetic Medicines | Regeneron » speaking at Advanced Therapies USA

Thomas Weber, CEO and Founder, Gene Therapy Consulting

Thomas Weber | CEO and Founder | Gene Therapy Consulting » speaking at Advanced Therapies USA

Jie Wei, Director, Bioanalytical Sciences, Tr1x, Inc

Jie Wei | Director, Bioanalytical Sciences | Tr1x, Inc » speaking at Advanced Therapies USA

Daniel Weiss, Professor of Medicine, Pulmonary Medicine Department of Medicine, University of Vermont

Daniel Weiss | Professor of Medicine, Pulmonary Medicine Department of Medicine | University of Vermont » speaking at Advanced Therapies USA

Rafal P. Witek, VP, Translational R&D, Head of Liver Program, Dimension Bio

Rafal P. Witek | VP, Translational R&D, Head of Liver Program | Dimension Bio » speaking at Advanced Therapies USA

Keith Wonnacott, Vice President Regulatory Affairs, Lexeo Therapeutics

Keith Wonnacott | Vice President Regulatory Affairs | Lexeo Therapeutics » speaking at Advanced Therapies USA

Jeff Wren, Vice President, Biotherapies, AABB

Jeff Wren | Vice President, Biotherapies | AABB » speaking at Advanced Therapies USA

Yuntao Wu, Professor, George Mason University

Howard Wu, Co-Founder & Chief Scientific Officer, Full Circles Therapeutics

Sareina Wu, Founder & CSO, Genomefrontier Therapeutics Inc

Sareina Wu | Founder & CSO | Genomefrontier Therapeutics Inc » speaking at Advanced Therapies USA

Guangai Xue, Senior Scientist, Cell Therapy Development Operations, Global Operations, AstraZeneca

Guangai Xue | Senior Scientist, Cell Therapy Development Operations, Global Operations | AstraZeneca » speaking at Advanced Therapies USA

Shadan Yarandi, Senior Scientist, Johnson & Johnson Innovative Medicine

Shadan Yarandi | Senior Scientist | Johnson & Johnson Innovative Medicine » speaking at Advanced Therapies USA

Andrew York, Executive Director, Maryland Prescription Drug Affordability Board

Andrew York | Executive Director | Maryland Prescription Drug Affordability Board » speaking at Advanced Therapies USA

Sarah Yuan, Chief Technology Officer, Cabaletta Bio

Sarah Yuan | Chief Technology Officer | Cabaletta Bio » speaking at Advanced Therapies USA

Nan Zhang, Chief, Cell Therapy Manufacturing Section, Center for Cellular Engineering, National Institutes of Health

Nan Zhang | Chief, Cell Therapy Manufacturing Section, Center for Cellular Engineering | National Institutes of Health » speaking at Advanced Therapies USA

Minghong Zhong, CEO, GeneLancet Biosciences, Inc.

David Zuzga, Associate Dean of Biomedical Studies, The Wistar Institute

Get Involved with the Advanced Therapies Congress

 

To sponsor or exhibit


Natasha Bangle
natasha.bangle@terrapinn.com
+44 20 3545 5515


Joshua Lloyd
Josh.Lloyd@terrapinn.com
+44 20 4614 9423

 

To speak


Chris Shanks
chris.shanks@terrapinn.com
+44 20 8152 7604